-
Confusion universal on prostate cancer screening, U.S. group charges
WASHINGTON, D.C. | The U.S. Prostate Cancer Roundtable has expressed concern about the utterly confusing guidance being offered – to both the professional healthcare community and to individual consumers – about whether men should or should not be tested ("screened") for risk of prostate cancer. -
Pharmaceutical sector's investment in Canada chronically underreported: KPMG
OTTAWA | For the third consecutive year, a KPMG study commissioned by Canada's Research-Based Pharmaceutical Companies (Rx&D) has determined that research and development investments made by Canada's innovative pharmaceutical sector continue to be consistently underreported, by approximately 34% for 2012.